Views & Analysis Live Well: when health and opportunity knocks Live Well brings health products to the doorsteps of rural Zambians in an innovative partnership between GSK and CARE International.
Views & Analysis Will Babylon’s app ever speak doctors’ language? Babylon Health might be one of the fastest developing digital health innovators in recent months.
Views & Analysis Case study: Ensuring safety by digitally linking prescriptio... Monitoring people who are on disease modifying drugs (DMDs) is paramount to providing safe, high-quality MS care.
Patients The time has come to optimise patient engagement A paradigm shift is occurring as patient engagement moves from an abstract concept to a pragmatic reality, and the evidence is already there to support this.
News Merck rare tumour drug Ezmekly backed for NHS use Merck's drug for tumours associated with rare disease neurofibromatosis type 1, Ezmekly, has been cleared for NHS use in children as young as two.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.